OR WAIT null SECS
New faces among the Pharma Industry rise the ranks.
TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced two executive appointments. Brian Flaherty will join the TrialScope team as Vice President of Business Development. Additionally, Thomas Wicks has been appointed to the position of Chief Strategy Officer (CSO). Brian Flaherty joins the TrialScope team with 19 years of sales experience including 10 years selling within the life sciences industry. Brian most recently held the position of Global Executive Director of Sales at Covance Clinical. In his new role, Brian will lead TrialScope’s sales efforts, including account management and new business development.
United BioSource Corp. (UBC), a subsidiary of Express Scripts, has appointed Don Gabriel, MD, PhD, an expert in targeted oncology treatments, to its Global Clinical Development & Operations team. Under the leadership of Sandra Lottes, PharmD, vice president of Global Clinical Development & Operations, Dr. Gabriel will direct UBC’s consultative services to pharmaceutical sponsors developing oncology therapies.
PRC Clinical, a Silicon-Valley based contract research organization announced today several management and executive appointments effective immediately. Mike Catelani will assume the role of Chief Financial Officer (CFO) and member of the Board of Directors.Daniel Head is appointed to Vice President of Business Operations, and Sue Dowden will assume the position of Senior Director of Clinical Operations. Tony Taricco, co-founder and current Chief Operations Officer (COO), has been appointed to the position of President and Chairman of the Board of Directors.
CTI Clinical Trial and Consulting Services Announces the Following New Hires:
CTI Clinical Trial and Consulting Services Announces the Following Promotions:
Pharmaceutical Product Development, LLC (PPD) today announced it has appointed Jon Denissen, Ph.D., as Vice President of Good Manufacturing Practices (GMP) laboratories. Denissen brings over 25 years of experience in the pharmaceutical and contract research organization (CRO) industries. He is based in PPD’s GMP lab facility in Middleton, Wisconsin.
“Jon’s experience includes successfully leading scientific teams and building effective client relationships that facilitate research collaboration,” said David Johnston, Ph.D., executive vice president of global laboratory services for PPD. “Our GMP laboratories provide fully integrated laboratory services for all phases of drug development, and Jon’s leadership will help drive PPD’s client-centric, quality-focused culture.”
BioClinica®, Inc., a specialty clinical trials services and technology provider, today announced the opening of a Research Triangle Park (RTP) office in North Carolina in response to a rapidly expanding customer base of study sponsors and Clinical Research Organizations with whom it has strategic partnerships.
“This strengthens our commitment in RTP as well as the greater Southern US,” BioClinica CEO John Hubbard said. BioClinica serves a dozen customers within the region, including a growing number of CROs that utilize its technology and support services to provide enhanced offerings to study sponsors. “The new quarters put us within arm’s reach of our customers,” Hubbard added.
Quintiles, the world’s largest biopharmaceutical services company, has been named to Forbes magazine’s first-ever “America’s Best Employers” list as rated by more than 20,000 independent survey responses. Quintiles is ranked as the 30th best employer in the United States and comes in third in the “Drugs and Biotechnology” category. In all, 500 companies are included in the 2015 Forbes list.
“Being named one of the top employers in the U.S. is a great honor for Quintiles and says a lot about our values, our people and company mission,” said Chief Human Resources Officer Garrett Walker. “Our organization is committed to building and sustaining a work environment that enables our talent to be high performing, successful in achieving their professional development goals and provides multiple career paths and opportunities.”
LabConnect, a leading global provider of central laboratory services, will be moving its operations center in Johnson City, Tenn., to a new, 42,000-square-foot custom-built facility effective May 7. LabConnect’s laboratory testing facility in Johnson City will remain in its current location.
“We have grown every year since we were founded in 2002, and we are committed to maintaining our facilities with cutting-edge technology,” said Eric Hayashi, LabConnect president and CEO. “The new operations center will triple our current space in Johnson City. This will provide room for state-of-the-art sample management and biorepository capabilities as well as space for efficient kit-building operations, redundant backup power generation, administrative offices and meeting rooms.”
Greenphire, the leading provider of payment technology for the clinical trials industry, today announced that it has formally moved its operations to new headquarters in King of Prussia, Philadelphia. The move quadruples the company's office space in the region and supports Greenphire's ongoing strategy for growth that will see the business rapidly scale its operational infrastructure to support its fast-growing global client base. The opening of Greenphire's new offices follows the recent significant investment by The Riverside Company and reflects the remarkable commercial and operational success Greenphire has enjoyed globally in the last five years.